Eye preparations, including a brain-derived nerve transfer factor (BDNF) at a concentration of at least 15 micrograms/micrograms, can be used to prevent and/or treat retinal neurodegenerative diseases, optical nerves and lateral genomes.
THE PRESENT INVENTION REFERRED TO AN OFFICIAL PREPARATION, LICENSE IN THE FORM OF EYE DROPS THAT INCLUDES A NEUROTROAcute FACTOR； DERIVED PHICO DOgt； BRAIN (BDNF) WAS A CONCENTRATION OF AT LEAST 15 PG / IL, AND A SOLUTION； NV (SCOSIFLCADA AS A PHARMACEUTICAL POWDER THAT UNDERSTANDS POLISACAacute； EXTRAIATE RIDO； DO OF SEEDS OF TAMARINDO CONCERNING)； WHICH WOULD VARY FROM 0.05 TO 2 emPLV, / IN WHICH IT IS USEFUL FOR PREVENTION, NY / OR PROCESSING OF NEURODEGENERATIVE DISEASES OF THE RETINA,Oacute； optics and skeletal anaphase； lt； / P gt；<；p>；LA PRESENTE INVENCIÓ；N SE REFIERO A UNA PREPARACIÓ；N OFTÁ；LMICA EN FORMA DE GOTAS PARA OJOS QUE COMPRENDE UN FACTOR NEUROTRÓ；FICO DERIVADO DO>； CEREBRO (BDNF) ERA UNA CONCENTRACIÓ；N DE AL MENOS 15 PG/IL, Y UNA SOLUCIÓ；N V(SCOSIFLCADA COMO PODADOR FARMACÉ；UTICAMONTE ACEPTABLE QUE COMPRENDE POLISACÁ；RIDO EXTRAÍ；DO DE SEMILLAS DE TAMARINDO (TSP) CON UNA CONCENTRACIÓ；N QUE VARIA DESDE 0,05 HASTA 2 <；em>；PLV, <；/em>；LA CUAL ES Ú；TIL PARA LN PREVENCIÓ；N Y/O TRALAMIENTO DO ENFERMEDADES NEURODEGENERATIVAS DE LA RETINA, NERVIO Ó；PTICO Y CUERPO GENICULAR LATERA).<；/p>；
